Tremblay D, Winters A, Beckman JD, et al. Splanchnic vein thrombosis associated with myeloproliferative neoplasms. Thromb Res. Published online August 5, 2022. doi:10.1016/j.thromres.2022.08.003 ...

In its statement, the EMA says that the PRAC reviewed 62 cases of CVST and 24 cases of thrombosis in the splanchnic vein reported in EudraVigilance (the European drug safety database), as of March 22.

LONDON – The EMA has concluded that the rare cases of serious blood clots with low platelet counts seen after administration of Astrazeneca plc’s COVID-19 vaccine are caused by the vaccine, but said ...

The mean age in the cohort was 57.9 years, and one-fourth of the patients (26%) had splanchnic vein thrombi, 34.5% had specific signs of portal hypertension, and 52.7% had nonspecific signs of ...

As of April 4, the EU drug safety database received 169 total cases of CVST and 53 cases of splanchnic vein thrombosis (SVT) amid a backdrop of 34 million vaccinated individuals.

Methods: We included the top three discharge diagnoses to identify cases of splanchnic vein thrombosis (portal/mesenteric/hepatic and splenic vein thrombosis) along with a secondary diagnosis of a GI ...

That included 287 cases of clotting - including CVST and splanchnic vein thrombosis (SVT) which is clotting in veins in the abdomen - linked to the AstraZeneca vaccine.

Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination: A Vascular Liver Disease Group (VALDIG) initiative Journal: Hepatology Published: 2024-02-16 DOI: 10.1097/hep.0000000000000787 ...